Decreased levels of serum complement C3 and natural killer cells add to the predictive value of total immunoglobulin G for severe infection in heart transplant recipients

Transplant Infectious Disease

Volumn 14, Issue 5, 2012, Pages 526-539

  Sarmiento, E ^a   del Pozo, N ^a   Gallego, A ^a   Fernandez Yanez J ^a   Palomo, J ^a   Villa, A ^a   Ruiz, M ^a   Munoz P ^a   Rodriguez C ^a   Rodriguez Molina J ^a   Navarro, J ^a   Kotsch, K ^b   Fernandez Cruz, E ^a   Carbone, J ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

C3 complement; Heart transplantation; IgG hypogammaglobulinemia; IgG2 subclass; Immune monitoring; Infection; Natural killer cell

Indexed keywords

COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CD3+ T LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL COUNT; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT RECIPIENT; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL MONITORING; INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PREDICTIVE VALUE; PRIORITY JOURNAL;

ADULT; COMPLEMENT C3; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOGLOBULIN G; INFECTION; KAPLAN-MEIER ESTIMATE; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; MONITORING, IMMUNOLOGIC; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 84867618349     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2012.00757.x     Document Type: Article

References (22)

1. Stehlik J, Edwards LB, Kucheryavaya AY, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report-2010. J Heart Lung Transplant 2010; 29 (10): 1089-1103.
2. Corales R, Chua J, Mawhorter S, et al. Significant post-transplant hypogammaglobulinemia in six heart transplant recipients: an emerging clinical phenomenon? Transpl Infect Dis 2000; 2 (3): 133-139.
3. Yamani MH, Avery RK, Mawhorter SD, et al. Hypogammaglobulinemia following cardiac transplantation: a link between rejection and infection. J Heart Lung Transplant 2001; 20 (4): 425-430.
4. Sarmiento E, Rodriguez-Molina JJ, Fernandez-Yañez J, et al. IgG monitoring to identify the risk for development of infection in heart transplant recipients. Transpl Infect Dis 2006; 8 (1): 49-53.
5. Sarmiento E, Rodríguez-Molina J, Muñoz P, et al. Decreased levels of serum immunoglobulins as a risk factor for infection after heart transplantation. Transplant Proc 2005; 37 (9): 4046-4049.
6. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-140.
7. Muñoz P, Rodriguez C, Bouza E, et al. Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis. Am J Transplant 2004; 4 (4): 636-643.
8. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24: 1710-1720.
9. Muñoz P, Palomo J, Muñoz R, et al. Tuberculosis in heart transplant recipients. Clin Infect Dis 1995; 21: 398-402.
10. Quezado ZM, Hoffman WD, Winkelstein JA, et al. The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure. J Exp Med 1994; 179 (2): 569-578.
11. Spiller OB, Hanna SM, Devine DV, Tufaro F. Neutralization of cytomegalovirus virions: the role of complement. J Infect Dis 1997; 176 (2): 339-347.
12. Hadaya K, de Rham C, Bandelier C, et al. Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation. Am J Transplant 2008; 8 (12): 2674-2683.
13. Bouzani M, Ok M, McCormick A, et al. Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN-γ release. J Immunol 2011; 187 (3): 1369-1376. Epub 2011 Jun 22.
14. Ekdahl K, Braconier JH, Svanborg C. Immunoglobulin deficiencies and impaired immune response to polysaccharide antigens in adult patients with recurrent community-acquired pneumonia. Scand J Infect Dis 1997; 29 (4): 401-407.
15. Lortan JE, Vellodi A, Jurges ES, Hugh-Jones K. Class- and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantation. Clin Exp Immunol 1992; 88 (3): 512-519.
16. Yamani MH, Avery R, Mawhorter SD, et al. The impact of CytoGam on cardiac transplant recipients with moderate hypogammaglobulinemia: a randomized single-center study. J Heart Lung Transplant 2005; 24 (11): 1766-1769.
17. Carbone J, del Pozo N, Gallego A, Sarmiento E. Immunological risk factors for infection after immunosuppressive and biologic therapies. Expert Rev Anti Infect Ther 2011; 9 (4): 405-413.
18. Carbone J, Lanio N, Gallego A, Sarmiento E. Immune monitoring to predict the development of infections after immunosuppression for solid organ transplantation and autoimmune diseases. Curr Drug Saf 2008; 3: 91-99.
19. Tomescu C, Abdulhaqq S, Montaner LJ. Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN). Clin Exp Immunol 2011; 164: 158-169.
20. Ogata K, An E, Shioi Y, et al. Association between natural killer cell activity and infection in immunologically normal elderly people. Clin Exp Immunol 2001; 124: 392-397.
21. Gordon CL, Johnson PD, Permezel M, et al. Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clin Infect Dis 2010; 50 (5): 672-678.
22. Homann C, Varming K, Høgåsen K, et al. Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality. Gut 1997; 40: 544-549.